Cambridge adult centre

This centre’s mission is to champion research excellence in experimental cancer medicine for patient benefit.

Centre overview

Our Cambridge adult experimental cancer medicine centre (ECMC) focuses on an integrated approach to the study of cancer, working with both the Mark Foundation Institute for Integrated Cancer Medicine and the University of Cambridge's Early Detection Institute.

The centre has a track record of delivering globally competitive translational research and impactful clinical biomarkers and diagnostic devices, with expertise in early phase trials using novel designs.

Their strategy focuses on:

early cancer innovations for risk prediction, detection and interception with minimally invasive technologies
personalised cancer medicine by accelerating access to genomic profiling and innovative trial designs
innovative cancer imaging, inventing probes, tracers and methods to diagnose, monitor and treat cancer more effectively
maximise big data use by integrating multimodal data streams
early collaboration with patient and public involvement representatives, academic and industry partners, to deliver novel therapeutics and technologies

There is also a paediatric centre in Cambridge.

Expertise

experimental approaches to early disease
window of opportunity studies
biomarkers for response and recurrence
first-in-human and first-in-class clinical trials
genomics
advanced cancer imaging
multimodal integrated cancer medicine, computational biology and clinical informatics

Key contacts

Bristi Basu - Centre lead

Bristi Basu is an Academic Consultant in Medical Oncology at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. She directs the Cambridge Cancer Trials Centre and co-leads the Cancer Research UK Cambridge Centre Pancreatic Cancer Programme. Her specialist research focus is on experimental cancer therapeutics, specifically hepato-pancreatic-biliary tumours.

Kate Donoghue - Centre business co-lead

Kate Donoghue is the Programme Manager for the adult ECMC and Cancer Core Europe at the Cancer Research UK Cambridge Centre. Kate also co-leads the Cambridge ECMC patient and public involvement (PPI) group, supporting PPI representatives in expanding their involvement in research.

Rachel Kyd - Centre business co-lead

Rachel Kyd is the Research and Development Commercial Lead at Cambridge University Hospitals NHS Foundation Trust. She oversees the setup of commercial studies and manages the national contract value review process, focusing on collaborating with local teams and industry partners to streamline study set up.

Cherry May Sanchez - Patient and public involvement lead

Cherry May Sanchez is programme lead for the Cancer Research UK Cambridge Centre Nursing and Allied Health Professionals Programme, focusing on collaborative community partnerships and system-wide approaches to improving cancer care and research. She also leads the Cambridge ECMC PPI group, supporting PPI representatives in expanding their involvement in research.

Contact details

Cambridge University Hospitals NHS Foundation Trust

Cambridge Cancer Trials Centre (CCTC), Box 279 (S4)

Addenbrooke’s Hospital

Hills Road

Cambridge

CB2 0QQ

Centre email:

ecmc@cancer.cam.ac.uk

Programme office email:

ecmcadmin@cancer.org.uk